New Book Announcement –Perspectives in Lung Cancer

Perspectives in Lung Cancer compiles basic and advanced topics on lung cancer pathology and treatment in a single volume. Chapters introduce the reader to chest and lung anatomy followed by the biology of lung cancer. Subsequent chapters delve into diagnostic methods for lung cancer while progressing into treatment options. The book culminates into an explanation of the concept of the Lung Cancer Centre, which is a representation of the editors’ vision for organizing a lung cancer treatment unit.

Key features:

  1. -Organizes key topics covering both standard and avante-garde topics related to lung cancer
  2. -All contributions are presented by experts in lung cancer treatment
  3. -Addresses basic biology of lung cancer
  4. -Provides information about 3D surgical planning, a relatively new concept in the field of thoracic surgery
  5. -Addresses the standard method of resection, VATS and Mini VATS
  6. -Covers the role of radiation and systemic anti-cancer therapies in lung cancer treatment
  7. -Provides a glimpse of modern methods such as image guided surgery and therapy, laser therapy, and photo-dynamic therapy
  8. -Covers the role of palliative care for lung cancer
  9. -Presents information about a visionary organization of a lung cancer unit and treatment centre

The combination of carefully organised chapters covering a wide array of topics make this reference an essential reference for healthcare professionals interested in acquiring a broad perspective on lung cancer treatment with the goal of improving patient outcomes.

Read out the full version here

New Book Announcement – Perspectives in Lung Cancer

Perspectives in Lung Cancer compiles basic and advanced topics on lung cancer pathology and treatment in a single volume. Chapters introduce the reader to chest and lung anatomy followed by the biology of lung cancer. Subsequent chapters delve into diagnostic methods for lung cancer while progressing into treatment options. The book culminates into an explanation of the concept of the Lung Cancer Centre, which is a representation of the editors’ vision for organizing a lung cancer treatment unit.

Key features:

  1. -Organizes key topics covering both standard and avante-garde topics related to lung cancer
  2. -All contributions are presented by experts in lung cancer treatment
  3. -Addresses basic biology of lung cancer
  4. -Provides information about 3D surgical planning, a relatively new concept in the field of thoracic surgery
  5. -Addresses the standard method of resection, VATS and Mini VATS
  6. -Covers the role of radiation and systemic anti-cancer therapies in lung cancer treatment
  7. -Provides a glimpse of modern methods such as image guided surgery and therapy, laser therapy, and photodynamic therapy
  8. -Covers the role of palliative care for lung cancer
  9. -Presents information about a visionary organization of a lung cancer unit and treatment centre

The combination of carefully organised chapters covering a wide array of topics make this reference an essential reference for healthcare professionals interested in acquiring a broad perspective on lung cancer treatment with the goal of improving patient outcomes. Read out the full version here

Press Release | Bentham Science announces an important new journal, ‘Coronaviruses’

bentham science news release

 

BENTHAM SCIENCE PUBLISHERS

Bentham Science announces an important new journal, Coronaviruses to cover the latest research on coronavirus- related outbreak and the methods employed to treat coronavirus infections. Every article in the first issue of the journal will be published as Open Access (Free-to-download) for a limited time period of three months. The Editor-in-Chief of the journal is Prof. D. Liu at the Wuhan Institute of Virology, Wuhan , China, a world leading institution on virus research. The Honorary Editors of the journal are Prof. Ferid Murad (Nobel Laureate) and Prof. Atta-Ur-Rahman, FRS (Academician Chinese Academy of Sciences, and UNESCO Science Laureate).

Coronaviruses will publish original research articles, letters, reviews/mini-reviews and guest edited thematic issues on all aspects of coronaviruses such as their origins, types, transmission, pathogenesis, epidemiological, demographic, clinical and genomic characteristics etc. The Journal will also cover case reports and studies on outbreak of coronaviruses, their symptoms, related diseases, prevention, treatment regimens and development of new drugs.

The journal will be essential reading for virologists, epidemiologists, microbiologists and healthcare workers interested in the latest information about coronaviridae. Visit the journal website for further details: https://benthamscience.com/journals/Coronaviruses/

 

Read full Press Release to find out more: https://www.eurekalert.org/pub_releases/2020-03/bsp-bsa031720.php

Join the Editorial Board | Coronaviruses

 

Coronaviruses-join-editorial-board

 

JOIN EDITORIAL BOARD FOR THE  JOURNAL

CORONAVIRUSES 

“NEW IN 2020”

 

Bentham Science is interested in appointing active Editorial Board Members for  the journal; Coronaviruses. If you are working in the related field of the journal and are interested in becoming an Editorial Board Member, please send us your CV and a list of publications. You can also recommend suitable colleagues for the same, and, if possible, send their CV along with their list of publications. 

 

Mention in the subject line the field of interest, and send your CV at: beena@benthamscience.net and hermain@benthamscience.net

CC: faizan@benthamscience.net

 

AIMS & SCOPE

Coronaviruses publishes original research articles, letters, reviews/mini-reviews, clinical trial and guest edited thematic issues on all aspects of coronaviruses such as their origins, types, transmission, pathogenesis, epidemiological, demographic, clinical and genomic characteristics etc.

The Journal also covers case reports and studies on outbreak of coronaviruses, their symptoms, related diseases, prevention, treatment and development of new therapeutics.

To know more about the journal, please visit: https://benthamscience.com/journals/coronaviruses/

Press Release | Exploring new ways to treat different cancers

PR 02.jpg

 

Bentham Science’s premier Anti-cancer drug discovery book series is now in its 10th volume.

Frontiers in Anti-Cancer Drug Discovery is one of the first drug discovery book series published by Bentham Science. The series is Edited by Dr. Atta-ur-Rahman, and M. Iqbal Choudhary. The tenth volume of the series features chapters covering the treatment and management of specific tumors such as hepatoblastoma and glioblastoma, the reole of different transporters and nanocarriers in anti-cancer medicine, advances in anti-cancer nanomedicine and polyphenols. The series continues to be an up-to-date source of information for pharmaceutical researchers, oncologists and molecular biologists studying cancer and devising treatment solutions for patients embattled with the disease. Read full press release to find out more at: https://www.eurekalert.org/pub_releases/2019-06/bsp-mao061919.php

Open Access Articles – Oncolytic Virotherapy for Breast Cancer Treatment

Journal Name: Current Gene Therapy

Author(s): Samia M. O`Bryan, J. Michael Mathis*.

Abstract:

Breast cancer continues to be a leading cause of mortality among women. While at an early stage, localized breast cancer is easily treated; however, advanced stages of disease continue to carry a high mortality rate. The discrepancy in treatment success highlights that current treatments are insufficient to treat advanced-stage breast cancer. As new and improved treatments have been sought, one therapeutic approach has gained considerable attention. Oncolytic viruses are uniquely capable of targeting cancer cells through intrinsic or engineered means. They come in many forms, mainly from four major virus groups as defined by the Baltimore classification system. These vectors can target and kill cancer cells, and even stimulate immunotherapeutic effects in patients. This review discusses not only individual oncolytic viruses pursued in the context of breast cancer treatment but also the emergence of combination therapies with current or new therapies, which has become a particularly promising strategy for treatment of breast cancer. Overall, oncolytic virotherapy is a promising strategy for increased treatment efficacy for advanced breast cancer and consequently provides a unique platform for personalized treatments in patients.

For more details, please visit: http://www.eurekaselect.com/165254

ARTICLE BY DISEASE – Anal Cancer: Focus on HIV-Positive Patients in the HAART Era

ARTICLE BY DISEASE ON “ANAL CANCER”

 

 

Abstract:

Anal cancer represents an increasing health problem, especially in immune-compromised patients, as HIVpositive patients. Notably, a significant higher incidence rate is reported among HIV infected patients with the advent of highly active antiretroviral therapy (HAART). To date, no randomised trial supports the correlation between existing screening strategies and reduced progression of anal intraepithelial neoplasia (AIN) to anal cancer or improved survival. Nevertheless, screening and treatment of AIN by topical agents should be implemented in high risk population. Data on invasive anal cancer treatment show that combined modality treatment (CMT) is the treatment of choice. Early reports on HIV-positive patients describe higher treatment toxicity and a relation with lower CD4 count and higher HIV viral load. More recently, reported outcomes seem to be similar in HIV-positive population and general population. Reports on a rise in local recurrence rates and in acute side effects along with a correlation with pre-treatment CD4 counts in HIV-positive patients, are not confirmed by all authors. The development of the first approved vaccine is a milestone in the field of anogenital cancers. However, many questions are still unresolved especially as concerns immunization in the setting of HIV infection.

 

 

For more details, please visit: http://www.eurekaselect.com/node/94357/article

 

 

THEMATIC ISSUE – DISCOVERY OF NEW MEDICATION FOR THE TREATMENT OF DEPRESSION CO MORBID WITH INFLAMMATORY DISEASES

 

THEMATIC ISSUE OF THE JOURNAL: Current Topics in Medicinal Chemistry

 

“DISCOVERY OF NEW MEDICATION FOR THE TREATMENT OF DEPRESSION COMORBID WITH INFLAMATORY DISEASES”

Current Topics in Medicinal Chemistry-Dr Hande Sipahi.jpg

 

 

Guest Editor: Dr. Hande Sipahi, Dr. F. Esra Onen Bayram

EDITOR’S CHOICE – The Real Impact of Target Therapy in Breast Cancer Patients

Journal: Current Cancer Drug Targets

Author(s): Sebastiano Bordonaro, Massimiliano Berretta, Antonino Carmelo Tralongo, Silvia Clementi, Brigida Stanzione, Paolo Tralongo*.

Graphical Abstract:

 

Abstract:

Over the last 15 years, we have seen a huge expansion of the development of drugs directed against biomolecular targets within breast cancer cells. The over-expression of certain receptors (ER, PgR, HER-2, VEGF-R), as well as alteration of several intracellular signal transduction pathways (the PI3K-AKT-mTOR pathway, MEK-MAPK pathway, loss of PTEN, etc …) has a great impact on the likelihood of recurrence and progression of the disease, influencing the natural history of breast cancer. The recent biomolecular classification of breast cancer (Luminal A / B, HER2- driven, Basal Like) allowed finally to identify specific treatments against molecular target to associate or not to traditional chemotherapy, and to use in relation to the prognosis of the disease. In the following paragraphs, we will set out the major targeted drug that have received indications in breast cancer, both in the localized and in advanced disease, referring to the specific target (hormonal receptors, HER2, VEGF, m-TOR, PARP etc …).

Read more here: http://www.eurekaselect.com/149941/article

 

 

EDITOR’S CHOICE – Diagnosis and Treatment of Drug-Resistant Tuberculosis – Current Respiratory Medicine Reviews

Journal: Current Respiratory Medicine Reviews

Author(s): Rafael Laniado-Laborin

Graphical Abstract:

 

Abstract:

Background: For decades there were no significant advances in the development of diagnostic procedures for drug resistant TB (DR-TB), or the availability of new, effective drugs specifically developed for DR-TB. Now, we have witnessed during the last decade, the arrival of several new diagnostic techniques and new drugs, already available for clinical use. This review aims to critically analyze evidence-based recommendations on the most recent developments in the diagnosis and treatment of multidrug-resistant tuberculosis (MDR.TB).

Methods: PubMed search for papers describing innovative diagnostic techniques and newer drugs and treatment regimens for MDR-TB. All World Health Organization (WHO) evidence-based guidelines on the subject of diagnostic techniques and new drugs and treatment regimens were also reviewed.

Results: 21 papers, 10 WHO guidelines and one Global Tuberculosis Report (2016) were included in the review. Nineteen were original papers on diagnostic techniques or newer drugs and 2 were editorials on the global burden of MDR-TB. One WHO global report dealt with the burden of MDRTB, 6 guidelines had evidence-based recommendations on newer diagnostic techniques for MDR-TB and 4 had evidence based recommendations on new drugs and treatment regimens for MDR-TB.

Conclusion: The findings of this review confirm that genotypic diagnostic methods have revolutionized the diagnosis of MDR-TB, from a process that used to take months to one that now takes just a few hours. Also, for the first time in more than 50 years, two new antituberculosis drugs, delamanid and bedaquiline, are now added to the armamentarium, a greatly needed alternative for the treatment of MDR-TB.

To access the article, please visit: http://www.eurekaselect.com/155876

 

 

%d bloggers like this: